Study to evaluate the efficacy of Systane Balance in reducing Symptoms and Inflammatory Biomarker expression of HLA-DR and Tear Film Cytokines in Dry Eye subjects with Lipid Deficiency

ID Number 13-0146

Principal Investigator(s)
Penny A Asbell

Department(s) or Division(s)


The primary objective of this study is to evaluate the ability of Systane Balance and Systane Gel to improve comfort over baseline after 30 days.

Contact Information
Safwan Kezbor
(212) 824-7644

Recruiting Patients: No